Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice
暂无分享,去创建一个
Chen-feng Qi | A. Kovalchuk | Hongsheng Wang | H. Morse | J. Hartley | Dong-Mi Shin | Z. Li | Jianxum Feng | T. Fredrickson | Torgny N Fredrickson
[1] Yasuhiro Imamura,et al. BLNK Binds Active H-Ras to Promote B Cell Receptor-mediated Capping and ERK Activation* , 2009, Journal of Biological Chemistry.
[2] M. Nussenzweig,et al. AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.
[3] D. Roopenian,et al. NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.
[4] F. Alt,et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.
[5] O. Ohara,et al. Discriminating gene expression profiles of memory B cell subpopulations , 2008, The Journal of experimental medicine.
[6] A. Plebani,et al. Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF1 , 2008, The Journal of Immunology.
[7] C. Picard,et al. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+IgD+CD27+ B cell repertoire in infants , 2008, The Journal of experimental medicine.
[8] P. L. Bergsagel,et al. AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. , 2008, Cancer cell.
[9] M. Gertz. New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression , 2008, Leukemia & lymphoma.
[10] T. Ried,et al. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements , 2007, The Journal of experimental medicine.
[11] I. Weissman,et al. Transcriptional Profiling of Antigen-Dependent Murine B Cell Differentiation and Memory Formation1 , 2007, The Journal of Immunology.
[12] E. Pinaud,et al. The 3′ IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype1 , 2007, The Journal of Immunology.
[13] M. Tomayko,et al. New markers for murine memory B cells that define mutated and unmutated subsets , 2007, The Journal of experimental medicine.
[14] M. Hallek,et al. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases , 2007, Oncogene.
[15] S. Tangye,et al. Human IgM+CD27+ B Cells: Memory B Cells or “Memory” B Cells?1 , 2007, The Journal of Immunology.
[16] I. Henderson,et al. Salmonella Induces a Switched Antibody Response without Germinal Centers That Impedes the Extracellular Spread of Infection1 , 2007, The Journal of Immunology.
[17] S. Janz,et al. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma. , 2007, Cancer research.
[18] Chen-feng Qi,et al. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. , 2007, Cancer research.
[19] B. Barlogie,et al. IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo , 2007, Leukemia.
[20] H. Woo,et al. Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia , 2007, BMC Genomics.
[21] S. Janz,et al. Myc translocations in B cell and plasma cell neoplasms. , 2006, DNA repair.
[22] H. Avraham,et al. Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice. , 2006, Blood.
[23] Joshy Jacob,et al. Identification of Memory B Cells Using a Novel Transgenic Mouse Model1 , 2006, The Journal of Immunology.
[24] M. Wasik,et al. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma , 2006, Oncogene.
[25] S. Nutt,et al. Early appearance of germinal center–derived memory B cells and plasma cells in blood after primary immunization , 2005, The Journal of experimental medicine.
[26] T. Ried,et al. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. , 2005, Cancer research.
[27] L. McHeyzer-Williams,et al. Antigen-specific memory B cell development. , 2005, Annual review of immunology.
[28] M. Shin,et al. Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl , 2004, The Journal of experimental medicine.
[29] M. Nussenzweig,et al. AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.
[30] S. Janz,et al. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. , 2004, The Journal of clinical investigation.
[31] R. Mulligan,et al. Critical Role for Hematopoietic Cell Kinase (Hck)-mediated Phosphorylation of Gab1 and Gab2 Docking Proteins in Interleukin 6-induced Proliferation and Survival of Multiple Myeloma Cells* , 2004, Journal of Biological Chemistry.
[32] M. Potter. Neoplastic development in plasma cells , 2003, Immunological reviews.
[33] K. Toellner,et al. Extrafollicular antibody responses , 2003, Immunological reviews.
[34] Andrea Califano,et al. Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Hatano,et al. Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. , 2002, Immunity.
[36] P. L. Bergsagel,et al. Chromosome translocations in multiple myeloma , 2001, Oncogene.
[37] T. Ried,et al. Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice , 2000, Genes, chromosomes & cancer.
[38] A. W. Harris,et al. Atlas Of Mouse Hematopathology , 2000 .
[39] H. Morse,et al. Accelerated Appearance of Multiple B Cell Lymphoma Types in NFS/N Mice Congenic for Ecotropic Murine Leukemia Viruses , 2000, Laboratory Investigation.
[40] R. Scheuermann,et al. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. , 2000, Advances in immunology.
[41] G. Dighiero,et al. Restricted Immunoglobulin Variable Region (Ig V) Gene Expression Accompanies Secondary Rearrangements of Light Chain Ig V Genes in Mouse Plasmacytomas , 1999, The Journal of experimental medicine.
[42] R. Bataille,et al. V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. , 1999, Blood.
[43] M. Potter,et al. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis. , 1999, International immunology.
[44] Andrew C. Chan,et al. BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells , 1999 .
[45] V. Kindler,et al. Quiescent memory B cells in human peripheral blood co‐express bcl‐2 and bcl‐xL anti‐apoptotic proteins at high levels , 1998, European journal of immunology.
[46] T. Giese,et al. Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions , 1998, The Journal of experimental medicine.
[47] A. Kovalchuk,et al. Deletional remodeling of c-myc-deregulating chromosomal translocations , 1997, Oncogene.
[48] S. Rudikoff,et al. Characterization of C57BL/6 plasmacytomas lacking a c‐myc translocation , 1997, International journal of cancer.
[49] K. Rajewsky,et al. Evidence for a large compartment of IgM-expressing memory B cells in humans. , 1997, Blood.
[50] J. Shaughnessy,et al. Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[51] T. Hirano,et al. [Interleukin-6 and its receptor]. , 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[52] A. W. Harris,et al. Lymphoid tumorigenesis by v-abl and BCR-v-abl in transgenic mice. , 1990, Current topics in microbiology and immunology.
[53] J. Croese,et al. Animal model of human disease. Multiple myeloma. , 1988, The American journal of pathology.
[54] S. Klinken,et al. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. , 1988, Journal of immunology.
[55] W. O'Fallon,et al. Multiple myeloma: significance of plasmablastic subtype in morphological classification. , 1985, Blood.
[56] C. Taylor,et al. Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases. , 1982, Blood.